Introduction to Chengdu Changhua Technology Co., Ltd.

Established in August 2006 with a registered capital of 21 million RMB, Chengdu Changhua Technology Co., Ltd. operates from a 4,000 m² facility. In June 2017, it was acquired by Humanwell Han Yuan (Shanghai) Industrial Development Co., Ltd., which oversees over 16 subsidiaries nationwide. As the group’s R&D, production, and sales hub in Western China, Changhua is located in Zone A of Chengdu Medical City in Wenjiang. This district focuses on building a “Three-Medical Integration” (medical care, medicine, and healthcare) health industry cluster, offering robust support for Changhua’s sustainable growth.  

The company holds certifications for developing, producing, and selling Class I, II, and III medical devices. It was recognized as a High-Tech Enterprise in 2021 and obtained ISO 9001:2015 (GB/T 19001-2016) and Medical Device Quality Management System certifications in 2023. Its facilities include a 1,400 m² Class 10,000 cleanroom, a 1,500 m² Class 100,000 purification workshop, and a 75 m² Class 10,000 testing lab. Equipped with advanced machinery like extruders, blow molders, ethylene oxide sterilizers, and GC analyzers, Changhua ensures rigorous quality control.  

Core product lines cover Anaesthesia, Urology, Dental, and Rehabilitation sectors. Innovations include single-use silicone endotracheal tubes, bronchial blockers, double-lumen tubes, and suction catheters. To date, 22 medical devices are registered with Sichuan Medical Products Administration. Collaborations with global experts have yielded 26 patents (plus 7 pending).  In 2024, Changhua filed 5 Class II and 1 Class III devices for approval. By 2025, 14 new products will launch in Wenjiang, advancing the company’s mission to address critical healthcare needs.  

Vision:To become a global leader in polymer medical consumables.  

We cordially invite you to visit and collaborate!